ConductScience.org, home

Paper808142

Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.

Clyde DF. Am J Trop Med Hyg, 1975. Cited by 352 papers, by iCite.

Cite this record

ConductScience Library. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Papers, record 808142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/808142

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.
PubMed
Journal
Am J Trop Med Hyg
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
352
iCite
Relative citation ratio, by iCite
7.83
iCite
Revised in PubMed
2019-05-16
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clyde DFD F

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApicomplexaMajor topic
ImmunizationMajor topic
MalariaMajor topic
Plasmodium falciparumMajor topic
Plasmodium vivaxMajor topic
Anopheles
Humans
Immunoglobulins
Male
Middle Aged

Source PubMed

Download CSV of topics

Trials4

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00367380Evaluation of Reproducibility of a Sporozoite Challenge Model for Plasmodium Vivax in Human VolunteersBackgroundClinicalTrials.gov
NCT01082341Immunization of Human Volunteers With P. Vivax Irradiated SporozoitesBackgroundClinicalTrials.gov
NCT01083095Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human VolunteersResultsClinicalTrials.gov
NCT04739917Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune VolunteersBackgroundClinicalTrials.gov

Download CSV of trials

Cited by117

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 352 citations.

PMIDTitleJournalYearIn PapersSource
39971939iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA.NPJ Vaccines2025https://conductscience.org/library/papers/39971939PubMed
39893367Controlled human malaria infection: overview and potential application in the evaluation of transmission-blocking interventions in malaria-endemic areas.Malar J2025https://conductscience.org/library/papers/39893367PubMed
38687615Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine.JCI Insight2024https://conductscience.org/library/papers/38687615PubMed
38656211Vaccines and monoclonal antibodies: new tools for malaria control.Clin Microbiol Rev2024https://conductscience.org/library/papers/38656211PubMed
38307966Profiling the antibody response of humans protected by immunization with Plasmodium vivax radiation-attenuated sporozoites.Sci Rep2024https://conductscience.org/library/papers/38307966PubMed
37936181Comparative analyses of functional antibody-mediated inhibition with anti-circumsporozoite monoclonal antibodies against transgenic Plasmodium berghei.Malar J2023https://conductscience.org/library/papers/37936181PubMed
37703302Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates.PLoS Negl Trop Dis2023https://conductscience.org/library/papers/37703302PubMed
37571809Sporozoite immunization: innovative translational science to support the fight against malaria.Expert Rev Vaccines2023https://conductscience.org/library/papers/37571809PubMed
37198702Malaria vaccines: the 60-year journey of hope and final success-lessons learned and future prospects.Trop Med Health2023https://conductscience.org/library/papers/37198702PubMed
37014087Memory CD8+ T cell-mediated protection against liver-stage malaria.Immunol Rev2023https://conductscience.org/library/papers/37014087PubMed
36685545The challenges of Plasmodium vivax human malaria infection models for vaccine development.Front Immunol2022https://conductscience.org/library/papers/36685545PubMed
36558821Cryopreservation of Plasmodium Sporozoites.Pathogens2022https://conductscience.org/library/papers/36558821PubMed
36343566Current approaches to malaria vaccines.Curr Opin Microbiol2022https://conductscience.org/library/papers/36343566PubMed
36159849Five decades of clinical assessment of whole-sporozoite malaria vaccines.Front Immunol2022https://conductscience.org/library/papers/36159849PubMed
36001680A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection.Sci Transl Med2022https://conductscience.org/library/papers/36001680PubMed
35734173Innate Immune Responses and P. falciparum CS Repeat-Specific Neutralizing Antibodies Following Vaccination by Skin Scarification.Front Immunol2022https://conductscience.org/library/papers/35734173PubMed
34376691Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection.NPJ Vaccines2021https://conductscience.org/library/papers/34376691PubMed
33995336Whole-Killed Blood-Stage Vaccine: Is It Worthwhile to Further Develop It to Control Malaria?Front Microbiol2021https://conductscience.org/library/papers/33995336PubMed
33481638Progress towards the development of a P. vivax vaccine.Expert Rev Vaccines2021https://conductscience.org/library/papers/33481638PubMed
32664476Potential and Limitations of Cross-Protective Vaccine against Malaria by Blood-Stage Naturally Attenuated Parasite.Vaccines (Basel)2020https://conductscience.org/library/papers/32664476PubMed

See all 117 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/808142

GET https://conductscience.org/api/papers/v1/808142/cited_by?page=2